Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > đź’Ľ Exciting Opportunity at University Hospitals of Leicester
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Post by jopatcloon Jun 24, 2024 12:35pm
73 Views
Post# 36103465

đź’Ľ Exciting Opportunity at University Hospitals of Leicester

đź’Ľ Exciting Opportunity at University Hospitals of LeicesterVery interesting ...
Robins profile photo
Robin Farrar-Hockley (MCIPD) reposted this
Exciting Opportunity at University Hospitals of Leicester NHS Trust!
We're thrilled to announce a position for a Highly Specialised Cardiac Physiologist in Congenital Echocardiography. Join our state-of-the-art facility equipped with advanced echocardiography machines, including the cutting-edge Ventripoint system.

Why Ventripoint Matters: Ventripoint enhances our echocardiographic capabilities with precise 3D heart reconstructions and detailed right ventricular analysis. This technology ensures comprehensive and accurate patient assessments, crucial for delivering top-notch cardiac care.

‍ Join us in providing outstanding cardiac services to our patients. Apply now and be a part of the innovative team!

More Details and Application https://lnkd.in/d-pjJCmE
 
 
 
 

 

 
Add a comment…
 

• 3rd+

TUPE and Redundancy expert and commercially aware HR support, direct to business owners and decision makers with straight up, no nonsense, HR solutions. | Chartered MCIPD | 07967441294 | farrarhockley@gmail.com
Reposted to my network
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities